ReferenceID 4887

Molecular Mechanisms of Palmitic Acid Augmentation in COVID-19 Pathologies

Int J Mol Sci

The coronavirus disease 2019 (COVID-19) pandemic has claimed over 2.7 million lives globally. Obesity has been associated with increased severity and mortality of COVID-19. However, the molecular mechanisms by which obes

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Ingredient: 1Reference: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final reference record.

Reference Id
4887
Evidence Id
21477
Core Evidence Id
21477
Source Reference Id
3020
Herb2 Reference Id
HBREF003817
Subject Paper Key
HBIN020174_34281182
Pubmed Id
34281182
Doi
10.3390/ijms22137127
Paper Title
Molecular Mechanisms of Palmitic Acid Augmentation in COVID-19 Pathologies
Paper Abstract
The coronavirus disease 2019 (COVID-19) pandemic has claimed over 2.7 million lives globally. Obesity has been associated with increased severity and mortality of COVID-19. However, the molecular mechanisms by which obesity exacerbates COVID-19 pathologies are not well-defined. The levels of free fatty acids (FFAs) are elevated in obese subjects. This study was therefore designed to examine how excess levels of different FFAs may affect the progression of COVID-19. Biological molecules associated with palmitic acid (PA) and COVID-19 were retrieved from QIAGEN Knowledge Base, and Ingenuity Pathway Analysis tools were used to analyze these datasets and explore the potential pathways affected by different FFAs. Our study found that one of the top 10 canonical pathways affected by PA was the coronavirus pathogenesis pathway, mediated by key inflammatory mediators, including PTGS2; cytokines, including IL1beta and IL6; chemokines, including CCL2 and CCL5; transcription factors, including NFkappaB; translation regulators, including EEF1A1; and apoptotic mediators, including BAX. In contrast, n-3 fatty acids may attenuate PA's activation of the coronavirus pathogenesis pathway by inhibiting the activity of such mediators as IL1beta, CCL2, PTGS2, and BAX. Furthermore, PA may modulate the expression of ACE2, the main cell surface receptor for the SARS-CoV-2 spike protein.
Journal
Int J Mol Sci
Publish Year
2021
Experiment Subject
Experiment Type
Cell Experiment
Phenotype Related
Obesity; Coronavirus Disease; Covid-19 Pathologies; Obese
Paper Title Cn
Paper Title En
Molecular Mechanisms of Palmitic Acid Augmentation in COVID-19 Pathologies
Bilingual Status
semi_complete